Tungsten Signs Dana Farber Cancer Institute And Fresenius Medical Care NA

E-Invoicing platform provider Tungsten Network has announced two new pharmaceutical businesses have selected them for e-invoicing; Dana-Farber Cancer Institute, a world leader in cancer treatment and research, and Fresenius Medical Care NA, a US-based provider of kidney dialysis services and renal care products, and

“The pharmaceutical sector has been an early adopter of e-Invoicing with our first customer from the industry joining the network in 2004,” says Edmund Truell, Tungsten Group CEO. “It’s befitting that an industry focused on innovation is equally pioneering in its own business practices.”

These new customers join t GlaxoSmithKline on Tungesten’s platform. The company reports that seven of the twelve largest pharmaceutical companies in the world, ranked by revenue, transact with their suppliers through Tungsten Network.